Stonepine Capital Management, LLC
CIK 1440771 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $177.3M
- Posisi
- 87
- Per tanggal
- 30 Juni 2026
#6.868 dari 9.443 berdasarkan nilai 13F · top 72.7%
Nilai portofolio QoQ: -29.0% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 44,39%
- Bobot 25 kepemilikan teratas
- 73,95%
- Posisi di atas 1%
- 29
- Jumlah posisi efektif
- 34,1
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 28,47% Perkiraan pembelian $60.773.415 · penjualan $146.049.602
Kepemilikan median: 2,0 kuartal Dilacak Q4 2024–Q2 2026 · 45,1% masih dipegang
- Posisi baru
- 25
- Meningkat
- 23
- Menurun
- 27
- Tertutup
- 13
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan Bernilai Tinggi Kepemilikan yang paling terkonsentrasi pada manajer ini.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
- Terkait Orang di balik pengaju ini, jika kami dapat mencocokkannya.
Kinerja vs S&P 500
Tahunan: +26.7% · S&P 500: +21.7%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 98,5% · Opsi dikecualikan: 24,0%
Rincian sektor
Healthcare
92,0%
Lainnya/Tidak terpetakan
8,0%
Portofolio lengkap 87 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| VSTM Verastem, Inc. - Common Stock | $12.795.575 | 7,22% | 3.349.627 | $-4.706.615 | Naik ×5 | ||
| EOLS Evolus, Inc. - Common Stock | $11.035.724 | 6,23% | 1.590.162 | $3.805.860 | Turun ×1 | ||
| TENX Tenax Therapeutics, Inc. - Common Stock | $9.603.000 | 5,42% | 660.000 | $-5.990.448 | Turun ×1 | ||
| NKTR Nektar Therapeutics - Common Stock | $8.422.856 | 4,75% | 120.654 | $2.307.106 | Naik ×1 | ||
| ADMA ADMA Biologics Inc - Common Stock | $7.950.000 | 4,48% | 650.000 | Opsi beli | $-2.411.500 | Turun ×1 | |
| ADMA ADMA Biologics Inc - Common Stock | $6.193.800 | 3,49% | 740.000 | $-473.600 | |||
| CAMP CAMP4 Therapeutics Corporation - Common Stock | $6.072.648 | 3,43% | 1.389.622 | $-55.585 | |||
| INSM Insmed Incorporated - Common Stock | $5.600.000 | 3,16% | 40.000 | Opsi beli | Naik ×1 | ||
| Penerbit tidak dikenal (CUSIP: 29014R301) | $5.512.581 | 3,11% | 397.160 | Naik ×1 | |||
| RARE Ultragenyx Pharmaceutical Inc. - Common Stock | $5.500.000 | 3,10% | 200.000 | Opsi beli | |||
| KZIA Kazia Therapeutics Limited - American Depositary Shares | $4.860.120 | 2,74% | 345.179 | $2.291.988 | |||
| MDT Medtronic plc. Ordinary Shares | $4.375.000 | 2,47% | 50.000 | Opsi beli | Naik ×1 | ||
| INDV Indivior Pharmaceuticals, Inc. - Common Stock | $4.103.000 | 2,31% | 100.000 | Naik ×1 | |||
| CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | $3.986.500 | 2,25% | 425.000 | $385.792 | Naik ×1 | ||
| ABT Abbott Laboratories Common Stock | $3.800.000 | 2,14% | 40.000 | Opsi beli | Naik ×1 | ||
| MSLE Satellos Bioscience Inc. - Common Stock | $3.723.291 | 2,10% | 491.624 | $3.160.291 | Naik ×1 | ||
| ZVRA Zevra Therapeutics, Inc. - Common Stock | $3.709.772 | 2,09% | 258.701 | $-763.828 | Turun ×3 | ||
| ABEO Abeona Therapeutics Inc. - Common Stock | $3.444.015 | 1,94% | 557.284 | $99.305 | Turun ×1 | ||
| BSX Boston Scientific Corporation Common Stock | $3.250.000 | 1,83% | 50.000 | Opsi beli | Naik ×1 | ||
| EDSA Edesa Biotech, Inc. - Common Shares | $3.190.807 | 1,80% | 456.439 | $3.033.907 | Naik ×1 | ||
| EOLS Evolus, Inc. - Common Stock | $3.150.000 | 1,78% | 420.000 | Opsi beli | $1.423.800 | ||
| BMRN BioMarin Pharmaceutical Inc. - Common Stock | $3.125.000 | 1,76% | 50.000 | Opsi beli | Naik ×1 | ||
| CABA Cabaletta Bio, Inc. - Common Stock | $2.852.181 | 1,61% | 917.100 | $2.717.681 | Naik ×1 | ||
| ANTX AN2 Therapeutics, Inc. - Common Stock | $2.670.190 | 1,51% | 551.692 | $228.840 | Turun ×1 | ||
| Penerbit tidak dikenal (CUSIP: 98422T209) | $2.165.023 | 1,22% | 225.994 | $1.625.421 | Naik ×1 | ||
| ACET Adicet Bio, Inc. - Common Stock | $2.121.276 | 1,20% | 245.518 | $609.762 | Naik ×2 | ||
| XERS Xeris Biopharma Holdings, Inc. - Common Stock | $2.100.000 | 1,18% | 280.000 | Opsi beli | $476.000 | ||
| TELA TELA Bio, Inc. - Common stock | $1.996.820 | 1,13% | 2.662.427 | $374.124 | Naik ×5 | ||
| AYTU Aytu BioPharma, Inc. - Common Stock | $1.962.780 | 1,11% | 912.921 | $-200.169 | Naik ×1 | ||
| CRIS Curis, Inc. - Common Stock | $1.729.292 | 0,98% | 3.312.185 | $-310.170 | Turun ×1 | ||
| SPRB Spruce Biosciences, Inc. - Common Stock | $1.554.930 | 0,88% | 28.795 | ||||
| HRTX Heron Therapeutics, Inc. - Common Stock | $1.500.000 | 0,85% | 1.000.000 | Opsi beli | $699.900 | ||
| SIBN SI-BONE, Inc. - Common Stock | $1.500.000 | 0,85% | 100.000 | Opsi beli | $237.000 | ||
| OKYO OKYO Pharma Limited - Ordinary Shares | $1.294.494 | 0,73% | 862.996 | $-74.006 | Naik ×1 | ||
| NMRA Neumora Therapeutics, Inc. - Common Stock | $1.250.000 | 0,71% | 500.000 | Opsi beli | $275.000 | ||
| KTTA Pasithea Therapeutics Corp. - Common Stock | $1.134.637 | 0,64% | 2.201.468 | $517.978 | Naik ×2 | ||
| SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | $1.072.732 | 0,61% | 14.469 | $-1.127.841 | Turun ×1 | ||
| LUNG Pulmonx Corporation - Common Stock | $1.060.067 | 0,60% | 815.436 | $68.975 | Naik ×2 | ||
| XFOR X4 Pharmaceuticals, Inc. - Common Stock | $1.050.699 | 0,59% | 224.989 | $-334.127 | Turun ×3 | ||
| ARDX Ardelyx, Inc. - Common Stock | $1.050.000 | 0,59% | 150.000 | Opsi beli | $151.500 | ||
| DCTH Delcath Systems, Inc. - Common Stock | $1.000.000 | 0,56% | 100.000 | Opsi beli | $72.000 | ||
| INAB IN8bio, Inc. - Common Stock | $980.355 | 0,55% | 695.287 | $-1.495 | Naik ×4 | ||
| MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | $973.500 | 0,55% | 50.000 | Naik ×1 | |||
| QNRX Quoin Pharmaceuticals, Ltd. - American Depositary Shares | $965.512 | 0,54% | 199.486 | $612.676 | Naik ×1 | ||
| MXCT MaxCyte, Inc. - Common Stock | $924.475 | 0,52% | 751.606 | $218.692 | Turun ×1 | ||
| PHAT Phathom Pharmaceuticals, Inc. - Common Stock | $922.358 | 0,52% | 85.010 | $366.747 | Naik ×1 | ||
| AZTR | $886.903 | 0,50% | 5.285.476 | Naik ×1 | |||
| CNTB Connect Biopharma Holdings Limited - Ordinary Shares | $866.925 | 0,49% | 364.254 | $54.725 | Naik ×1 | ||
| HELP Cybin Inc. - Common Stock | $854.541 | 0,48% | 129.280 | $211.053 | Turun ×2 | ||
| RARE Ultragenyx Pharmaceutical Inc. - Common Stock | $834.750 | 0,47% | 25.000 | ||||
| IKT Inhibikase Therapeutics, Inc. - Common Stock | $804.243 | 0,45% | 396.179 | $-803.856 | Turun ×2 | ||
| ZNTL Zentalis Pharmaceuticals, Inc. - common stock | $783.678 | 0,44% | 161.583 | $153.984 | Turun ×2 | ||
| CTMX CytomX Therapeutics, Inc. - Common Stock | $768.750 | 0,43% | 205.000 | $-171.250 | Naik ×1 | ||
| MNKD MannKind Corporation - Common Stock | $750.000 | 0,42% | 250.000 | Opsi beli | $-475.000 | Turun ×1 | |
| NVCT Nuvectis Pharma, Inc. - Common Stock | $735.600 | 0,41% | 40.000 | Naik ×1 | |||
| CBIO Crescent Biopharma, Inc. - Common Stock | $720.000 | 0,41% | 40.000 | $-841.450 | Turun ×2 | ||
| PMVP PMV Pharmaceuticals, Inc. - Common Stock | $718.355 | 0,41% | 536.086 | $-159.691 | Turun ×3 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $713.775 | 0,40% | 7.500 | Naik ×1 | |||
| RADX Radiopharm Theranostics Limited - American Depositary Shares | $670.500 | 0,38% | 51.000.000 | $-68.477 | |||
| OKUR OnKure Therapeutics, Inc. - Class A Common Stock | $595.919 | 0,34% | 130.684 | $47.046 | Turun ×1 | ||
| NGEN NervGen Pharma Corp. - Common stock | $559.657 | 0,32% | 271.678 | Naik ×1 | |||
| CALC CalciMedica, Inc. - Common Stock | $544.939 | 0,31% | 622.432 | ||||
| ARVN Arvinas, Inc. - Common Stock | $498.600 | 0,28% | 60.000 | $207.100 | Naik ×1 | ||
| BIOA BioAge Labs, Inc. - Common Stock | $490.200 | 0,28% | 20.000 | $-384.300 | Turun ×1 | ||
| IRD Opus Genetics, Inc. - Common Stock | $413.951 | 0,23% | 100.718 | $101.421 | Naik ×1 | ||
| QTI QT Imaging Holdings, Inc. - Common Stock | $407.000 | 0,23% | 100.000 | Naik ×1 | |||
| BOLD Boundless Bio, Inc. - Common Stock | $386.488 | 0,22% | 154.595 | $-270.962 | Turun ×2 | ||
| SINT SiNtx Technologies, Inc. - Common Stock | $332.531 | 0,19% | 209.205 | Naik ×1 | |||
| CLRB Cellectar Biosciences, Inc. - Common Stock | $290.649 | 0,16% | 104.550 | Naik ×1 | |||
| EPRX Eupraxia Pharmaceuticals Inc. - Common Stock | $287.476 | 0,16% | 43.491 | Naik ×1 | |||
| SABS SAB Biotherapeutics, Inc. - Common Stock | $285.757 | 0,16% | 73.271 | $94.257 | Naik ×1 | ||
| ANL Adlai Nortye Ltd. - American Depositary Shares | $278.956 | 0,16% | 24.257 | Naik ×1 | |||
| SENS Senseonics Holdings, Inc. - Common Stock | $276.502 | 0,16% | 48.680 | Naik ×1 | |||
| PLRX Pliant Therapeutics, Inc. - Common Stock | $262.813 | 0,15% | 230.538 | $-20.246 | Naik ×1 | ||
| CDXS Codexis, Inc. - Common Stock | $247.836 | 0,14% | 109.662 | $-433.494 | Turun ×1 | ||
| POCI Precision Optics Corporation, Inc. - Common stock | $236.589 | 0,13% | 46.390 | $-202.411 | Turun ×1 | ||
| UPB Upstream Bio, Inc. - Common Stock | $231.349 | 0,13% | 33.432 | $-83.651 | Turun ×1 | ||
| RNTX Rein Therapeutics, Inc. - Common Stock | $226.760 | 0,13% | 218.038 | Naik ×1 | |||
| HRTX Heron Therapeutics, Inc. - Common Stock | $209.468 | 0,12% | 490.787 | $-912.425 | Turun ×1 | ||
| CNSP CNS Pharmaceuticals, Inc. - Common Stock | $198.719 | 0,11% | 41.573 | $52.929 | Turun ×1 | ||
| HUMA Humacyte, Inc. - Common Stock | $180.506 | 0,10% | 231.299 | Naik ×1 | |||
| KLRS Kalaris Therapeutics, Inc. - Common Stock | $122.597 | 0,07% | 30.122 | $4.889 | Naik ×1 | ||
| PCSA Processa Pharmaceuticals, Inc. - Common Stock | $105.600 | 0,06% | 55.000 | $-33.275 | |||
| Penerbit tidak dikenal (CUSIP: 09077B203) | $68.028 | 0,04% | 16.432 | Naik ×1 | |||
| CGEN Compugen Ltd. - Ordinary Shares | $67.168 | 0,04% | 31.387 | $-154.991 | Turun ×2 | ||
| OVID Ovid Therapeutics Inc. - Common Stock | $57.297 | 0,03% | 21.300 | $-31.503 | Turun ×2 | ||
| EVAX Evaxion A/S - American Depositary Share | $54.442 | 0,03% | 17.562 | $-18.890 | Turun ×2 | ||
| Tidak ada hasil | |||||||
Kepemilikan dengan keyakinan
Posisi meningkat selama 3+ kuartal berturut-turut.
Jumlah saham dilaporkan dalam pengajuan 13F (tidak disesuaikan split)
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| INSM | $5.600.000 | 40.000 | 3,16% |
| Penerbit tidak dikenal (CUSIP: 29014R301) | $5.512.581 | 397.160 | 3,11% |
| RARE | $5.500.000 | 200.000 | 3,10% |
| MDT | $4.375.000 | 50.000 | 2,47% |
| INDV | $4.103.000 | 100.000 | 2,31% |
| ABT | $3.800.000 | 40.000 | 2,14% |
| BSX | $3.250.000 | 50.000 | 1,83% |
| BMRN | $3.125.000 | 50.000 | 1,76% |
| SPRB | $1.554.930 | 28.795 | 0,88% |
| MLTX | $973.500 | 50.000 | 0,55% |
| AZTR | $886.903 | 5.285.476 | 0,50% |
| RARE | $834.750 | 25.000 | 0,47% |
| NVCT | $735.600 | 40.000 | 0,41% |
| ORKA | $713.775 | 7.500 | 0,40% |
| NGEN | $559.657 | 271.678 | 0,32% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| TENX | Dipangkas | -315K | -$6.0M |
| VSTM | Beli lebih banyak | +47K | -$4.7M |
| EOLS | Dipangkas | -169K | +$3.8M |
| ADMA | Dipangkas | -500K | -$2.4M |
| NKTR | Beli lebih banyak | +36K | +$2.3M |
| KZIA | Hanya pergerakan harga | +0 | +$2.3M |
| — | Beli lebih banyak | +162K | +$1.6M |
| EOLS | Hanya pergerakan harga | +0 | +$1.4M |
| SLGL | Dipangkas | -13K | -$1.1M |
| CBIO | Dipangkas | -45K | -$841K |
4 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| XBI | 30 Juni 2026 | 800.000 | $102.184.000 | Tidak lagi dilacak |
| OPTN | 30 Juni 2025 | 788.647 | $7.231.893 | Tidak lagi dilacak |
| TERN | 30 Juni 2026 | 100.000 | $5.272.000 | Tidak lagi dilacak |
| URGN | 30 Juni 2025 | 333.400 | $3.687.404 | 261,5% |
| INDV | 31 Maret 2026 | 100.000 | $3.588.000 | 30,0% |
| ESTA | 30 Juni 2026 | 56.000 | $3.179.680 | -11,6% |
| ITOS | 30 Sep. 2025 | 310.033 | $3.091.029 | Tidak lagi dilacak |
| AQST | 30 Juni 2025 | 200.000 | $3.039.973 | 35,2% |
| IRWD | 31 Maret 2025 | 648.785 | $2.874.118 | 201,0% |
| CRSP | 31 Maret 2026 | 50.000 | $2.622.000 | 19,6% |
| ANIP | 30 Sep. 2025 | 38.597 | $2.518.454 | -13,8% |
| GLPG | 30 Juni 2025 | 93.968 | $2.360.476 | Tidak lagi dilacak |
| ARE | 30 Juni 2026 | 50.000 | $2.321.000 | -7,4% |
| RARE | 31 Maret 2026 | 100.000 | $2.300.000 | 26,0% |
| ACAD | 30 Juni 2026 | 100.000 | $2.226.000 | 21,2% |
| XOMA | 30 Juni 2026 | 69.500 | $2.180.215 | Tidak lagi dilacak |
| ANIK | 30 Sep. 2025 | 190.590 | $2.016.442 | 130,5% |
| DAWN | 31 Maret 2026 | 200.000 | $1.864.000 | Tidak lagi dilacak |
| SPRB | 31 Maret 2026 | 19.742 | $1.719.726 | -18,7% |
| EDSA | 30 Juni 2025 | 687.500 | $1.677.500 | 189,2% |
| SLNO | 31 Des. 2025 | 24.000 | $1.622.400 | Tidak lagi dilacak |
| ENTA | 31 Maret 2026 | 100.000 | $1.577.000 | 6,2% |
| MIST | 31 Maret 2026 | 662.666 | $1.338.585 | -8,4% |
| YMAB | 30 Sep. 2025 | 285.300 | $1.286.703 | Tidak lagi dilacak |
| JAZZ | 31 Maret 2025 | 10.000 | $1.231.500 | 105,3% |
| COLL | 30 Sep. 2025 | 41.500 | $1.227.155 | -16,1% |
| ALMS | 31 Des. 2025 | 300.000 | $1.197.000 | 161,8% |
| KALV | 30 Sep. 2025 | 100.000 | $1.130.500 | Tidak lagi dilacak |
| ARDX | 31 Des. 2025 | 200.000 | $1.102.000 | -31,1% |
| DVAX | 31 Des. 2025 | 108.094 | $1.073.373 | Tidak lagi dilacak |
| GERN | 31 Maret 2026 | 805.800 | $1.063.656 | 5,7% |
| KROS | 30 Juni 2025 | 100.000 | $1.019.000 | -18,7% |
| MYO | 30 Sep. 2025 | 457.419 | $988.025 | Tidak lagi dilacak |
| KZR | 31 Maret 2026 | 156.179 | $982.366 | Tidak lagi dilacak |
| VNDA | 31 Des. 2025 | 195.000 | $973.050 | -36,8% |
| SRZN | 30 Juni 2026 | 33.005 | $961.436 | -6,9% |
| XERS | 30 Sep. 2025 | 205.100 | $957.817 | 10,1% |
| SCPH | 30 Juni 2025 | 347.687 | $914.417 | Tidak lagi dilacak |
| VIR | 31 Des. 2025 | 160.000 | $913.600 | 65,0% |
| TSVT | 31 Maret 2025 | 300.000 | $882.000 | Tidak lagi dilacak |
| INO | 30 Juni 2025 | 518.331 | $844.880 | -39,5% |
| PROF | 30 Juni 2025 | 139.942 | $814.462 | 22,5% |
| SMLR | 31 Maret 2026 | 50.000 | $764.500 | Tidak lagi dilacak |
| ACHV | 30 Sep. 2025 | 333.333 | $753.333 | 146,0% |
| THRD | 30 Juni 2025 | 212.783 | $738.357 | Tidak lagi dilacak |
| ANGO | 31 Des. 2025 | 60.000 | $670.200 | 26,3% |
| GOSS | 31 Maret 2026 | 204.770 | $634.787 | -53,5% |
| GRCE | 31 Des. 2025 | 211.010 | $628.177 | -37,0% |
| LQDA | 30 Sep. 2025 | 50.000 | $623.000 | 224,7% |
| SNDX | 31 Des. 2025 | 37.200 | $572.322 | -2,3% |
| AQST | 31 Des. 2025 | 100.600 | $562.354 | -30,7% |
| VRCA | 30 Juni 2026 | 99.735 | $527.598 | -18,0% |
| CADL | 30 Juni 2026 | 102.500 | $502.250 | 23,7% |
| SPRO | 30 Sep. 2025 | 156.888 | $454.975 | -35,6% |
| HLVX | 30 Sep. 2025 | 226.009 | $449.758 | Tidak lagi dilacak |
| THTX | 30 Sep. 2025 | 189.051 | $446.160 | Tidak lagi dilacak |
| HCAT | 31 Des. 2025 | 155.551 | $443.320 | -25,1% |
| ESTA | 31 Des. 2025 | 10.585 | $433.879 | 4,1% |
| SLRN | 30 Juni 2025 | 167.580 | $413.923 | Tidak lagi dilacak |
| CTMX | 31 Des. 2025 | 125.000 | $398.750 | -17,4% |
| NBP | 30 Juni 2025 | 483.647 | $398.477 | -18,6% |
| SEPN | 30 Juni 2025 | 68.084 | $394.206 | 316,4% |
| FENC | 31 Maret 2026 | 50.000 | $385.000 | 93,0% |
| RZLT | 31 Des. 2025 | 40.000 | $376.000 | 104,0% |
| ACRS | 31 Des. 2025 | 192.900 | $366.510 | 111,3% |
| XGN | 30 Juni 2025 | 95.747 | $343.732 | -1,9% |
| HSDT | 31 Des. 2025 | 20.000 | $297.800 | -37,7% |
| JANX | 30 Juni 2026 | 20.000 | $278.000 | 12,6% |
| RNXT | 30 Juni 2025 | 278.188 | $275.406 | -8,9% |
| ANTX | 31 Maret 2025 | 196.732 | $271.490 | 338,2% |
| KPRX | 31 Maret 2026 | 131.144 | $258.354 | 31,6% |
| OABI | 30 Juni 2026 | 164.045 | $257.551 | 60,4% |
| TNYA | 31 Maret 2026 | 352.001 | $250.449 | 4,0% |
| SVRA | 31 Des. 2025 | 60.000 | $214.200 | -9,5% |
| ABVX | 31 Des. 2025 | 2.500 | $212.250 | -11,0% |
| ACET | 30 Juni 2025 | 508.266 | $203.500 | 1430,3% |
| CRGX | 30 Juni 2025 | 50.000 | $203.500 | Tidak lagi dilacak |
| MIST | 30 Juni 2025 | 250.000 | $200.025 | -43,8% |
| CRBP | 30 Juni 2025 | 35.000 | $185.850 | 48,8% |
| NUVB | 30 Sep. 2025 | 85.300 | $166.335 | 99,2% |
| PYPD | 30 Juni 2025 | 54.975 | $148.982 | 33,7% |
| KURA | 30 Sep. 2025 | 25.000 | $144.250 | 43,8% |
| CLYM | 30 Sep. 2025 | 116.147 | $144.022 | 770,3% |
| CALC | 30 Sep. 2025 | 85.000 | $136.000 | -80,0% |
| GLUE | 30 Sep. 2025 | 30.000 | $135.300 | 115,0% |
| ELEV | 31 Maret 2025 | 200.000 | $112.520 | Tidak lagi dilacak |
| ABVX | 31 Maret 2025 | 15.000 | $109.800 | 1821,0% |
| ELDN | 30 Juni 2026 | 35.000 | $107.800 | -7,4% |
| AMRNXXXX | 30 Juni 2025 | 651.614 | $105.000 | Tidak lagi dilacak |
| ELAN | 30 Juni 2025 | 10.000 | $105.000 | 71,2% |
| WHWK | 30 Juni 2025 | 46.698 | $83.122 | 161,0% |
| XLO | 31 Maret 2026 | 126.270 | $80.838 | 10,5% |
| LRMR | 31 Des. 2025 | 25.000 | $80.750 | 11,9% |
| CMMB | 31 Des. 2025 | 30.000 | $78.900 | 16,4% |
| ALLR | 31 Maret 2025 | 67.289 | $78.728 | 45,1% |
| RVNC | 31 Maret 2025 | 23.264 | $70.723 | Tidak lagi dilacak |
| WHWK | 31 Des. 2025 | 35.253 | $66.981 | 101,7% |
| IOVA | 30 Juni 2025 | 20.000 | $66.600 | 342,7% |
| JSPR | 31 Des. 2025 | 20.200 | $48.076 | -58,5% |
| CHRS | 30 Sep. 2025 | 62.700 | $45.853 | -18,6% |
| EBS | 30 Juni 2025 | 5.000 | $24.300 | -24,4% |
| NKTX | 30 Juni 2025 | 10.000 | $18.400 | 52,5% |
| APRE | 30 Juni 2025 | 102.242 | $14.400 | -58,9% |
| ESPR | 30 Juni 2025 | 10.000 | $14.400 | Tidak lagi dilacak |
| BCAB | 30 Juni 2026 | 65.387 | $10.527 | -22,0% |